for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

NantHealth Inc

NH.OQ

Latest Trade

0.81USD

Change

0.01(+1.62%)

Volume

2,766

Today's Range

0.78

 - 

0.85

52 Week Range

0.45

 - 

1.96

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.80
Open
0.78
Volume
2,766
3M AVG Volume
3.20
Today's High
0.85
Today's Low
0.78
52 Week High
1.96
52 Week Low
0.45
Shares Out (MIL)
110.63
Market Cap (MIL)
88.35
Forward P/E
-3.26
Dividend (Yield %)
--

Latest Developments

More

Nanthealth Q2 Revenue Rose 17% To $25.7 Mln

Nanthealth Received Non Compliance Notice From Nasdaq

Nanthealth Reports Q1 Loss Per Share $0.18 From Continuing Operations

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About NantHealth Inc

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. As of December 31, 2017, the Company conducted its operations primarily in the United States, Canada, the United Kingdom and Singapore. Its solutions include molecular profiling solution, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine, enabling care and clinical practice. Its cancer care solutions include a set of interoperability, diagnostics, risk stratification and decision support solutions (Eviti). Its systems infrastructure collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from sources to improve decision-making.

Industry

Software & Programming

Contact Info

9920 JEFFERSON BLVD

+1.310.8537513

https://nanthealth.com/

Executive Leadership

Patrick Soon-Shiong

Chairman of the Board, Chief Executive Officer, Founder

Bob Petrou

Interim Chief Financial Officer

Ronald Louks

Chief Operating Officer, Director

Michael D. Blaszyk

Independent Director

Kirk K. Calhoun

Independent Director

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.1K

2017

0.1K

2018

0.1K

2019(E)

0.1K
EPS (USD)

2016

-0.690

2017

-0.470

2018

-0.410

2019(E)

-0.245
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.93
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-59.90
Return on Equity (TTM)
-53.30

Latest News

BRIEF-NantHealth Reports Q1 Revenue $22.3 Mln

* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.12 FROM CONTINUING OPERATIONS

BRIEF-Nanthealth Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing

* NANTHEALTH INC FILES FOR MIXED SHELF OF UP TO $200 MILLION – SEC FILING Source text (http://bit.ly/2tTIk1d) Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Nanthealth Reports Q4 Loss Per Share $0.20

* NANTHEALTH REPORTS 2017 FOURTH-QUARTER AND FULL-YEAR FINANCIAL RESULTS

BRIEF-NantHealth reports 2017 third quarter financial results

* NantHealth reports 2017 third quarter financial results; GPS revenue doubles from preceding quarter

BRIEF-NantHealth reports Q2 loss per share $0.58

* NantHealth reports 2017 second quarter financial results; implements plan to focus on core competencies, enhance profitability and position for growth of artificial intelligence for cancer care

BRIEF-NantHealth - co entered asset purchase agreement with Allscripts Healthcare

* NantHealth Inc - on August 3, co entered asset purchase agreement with Allscripts Healthcare - SEC filing

BRIEF-Nanthealth Inc - ‍Blue Cross and Blue Shield of Nebraska has signed a three-year contract extension for NaviNet Open​

* Nanthealth Inc - Blue Cross and Blue Shield of Nebraska has signed a three-year contract extension for NaviNet Open Source text for Eikon: Further company coverage:

BRIEF-Nanthealth Q1 adjusted non-gaap loss per share $0.24

* Nanthealth reports 16% increase in 2017 first quarter total net revenue; saas revenue rose 11% and gps adoption continues to climb

BRIEF-Nanthealth appoints Dr. Sandeep Reddy as CMO

* Nanthealth appoints Dr. Sandeep Reddy as chief medical officer Source text for Eikon: Further company coverage:

BRIEF-Nanthealth posts Q4 adj. loss per share $0.18

* Nanthealth reports 72 pct increase in full year 2016 total net revenue to $100 million with saas revenue increasing more than 181 pct and increasing GPS cancer adoption

BRIEF-NantHealth reports Q3 loss per share $0.30

* NantHealth reports 76% increase in total Q3 net revenue 2016 versus 2015, gross profit triples

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up